MoFo Life Sciences

May 25, 2023 - Announcements, Healthcare, Regulatory, United States
New York Enacts Material Healthcare Transactions Notice Requirements: Four Key Takeaways
On May 3, 2023, New York Governor Kathy Hochul signed into law an amendment to the New York Public Health Law that will require certain healthcare entities to provide the State Department of Health (DOH) with written notice and supporting documentation of “material transactions”
... ›
May 03, 2023 - Announcements, Healthcare, Litigation, Regulatory, United States, FDA
FTC Issues Notice of Penalty Offenses on Substantiation of Product Claims
By: Brigid DeCoursey Bondoc and Claudia M. Vetesi
On April 13, 2023, the Federal Trade Commission (FTC) sent approximately 670 notices of penalty offenses to various companies involved in the marketing of OTC drugs, homeopathic products, dietary supplements, and functional foods, placing them on notice that they could incur significant civil penalties
... ›
April 20, 2020 - Corporate + Venture Capital, Agtech, Announcements
Morrison & Foerster Expands Corporate Capabilities Adding New Corporate Co-Chair Mitchell Presser
By: Mitchell S. Presser
Morrison & Foerster is pleased to announce the continued expansion of its New York office and global Corporate Department capabilities with the arrival of corporate partner Mitchell Presser. He joins the firm as a partner in its Mergers + Acquisitions and Private Equity Investments + Buyouts practices and
... ›
January 15, 2020 - United States, FDA, Announcements
2020 Under Dr. Stephen Hahn, FDA’s New Commissioner
By: Julie Y. Park
Last month, Dr. Stephen Hahn was officially sworn in as the new commissioner of the U.S. Food and Drug Administration (FDA). The Senate confirmed him by a 73-17 vote. Hahn became the fourth leader of FDA in 2019 and the first confirmed nominee since
... ›
February 05, 2019 - Announcements
Morrison & Foerster Opens Boston Office, Further Expanding Premier Technology and Life Sciences Capabilities
Morrison & Foerster, a leading global law firm, is pleased to announce that it has opened an office in Boston to further extend its market-leading technology and life sciences capabilities. The move also expands the firm’s premier Finance and Emerging Companies and Venture Capital (ECVC) practices. Additionally, the
... ›
January 01, 2017 - Announcements
Welcome to MoFo Life Sciences
MoFo Life Sciences shares timely legal and business insights and in-depth analyses on trends and the complex technologies at the heart of the global pharmaceutical, biotechnology, diagnostics, medical devices, digital health, and AgTech fields.
... ›

Topic Archives: Announcements

New York Enacts Material Healthcare Transactions Notice Requirements: Four Key Takeaways

FTC Issues Notice of Penalty Offenses on Substantiation of Product Claims

By: Brigid DeCoursey Bondoc and Claudia M. Vetesi

Morrison & Foerster Expands Corporate Capabilities Adding New Corporate Co-Chair Mitchell Presser

By: Mitchell S. Presser

2020 Under Dr. Stephen Hahn, FDA’s New Commissioner

By: Julie Y. Park

Morrison & Foerster Opens Boston Office, Further Expanding Premier Technology and Life Sciences Capabilities

Welcome to MoFo Life Sciences